Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Spinal Diseases × Melphalan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 176 Lymphoma 95 Lymphoma, Non-Hodgkin 83 Leukemia, Myeloid, Acute 79 Myelodysplastic Syndromes 73 Precursor Cell Lymphoblastic Leukemia-Lymphoma 72 Leukemia 62 Hodgkin Disease 62 Neoplasms, Plasma Cell 60 Leukemia, Lymphocytic, Chronic, B-Cell 53 Lymphoma, Large B-Cell, Diffuse 47 Lymphoma, Mantle-Cell 42 Lymphoma, Follicular 40 Burkitt Lymphoma 35 Lymphoma, Large-Cell, Immunoblastic 31 Lymphoma, B-Cell, Marginal Zone 29 Myeloproliferative Disorders 27 Recurrence 26 Neuroblastoma 24 Hematologic Neoplasms 24 Leukemia, Myeloid, Accelerated Phase 23 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 23 Leukemia, Myelomonocytic, Chronic 22 Leukemia, Myeloid, Chronic-Phase 21 Primary Myelofibrosis 18 Immunoglobulin Light-chain Amyloidosis 18 Graft vs Host Disease 18 Congenital Abnormalities 18 Dendritic Cell Sarcoma, Interdigitating 16 Blast Crisis 16

Interventions

Radiotherapy 1 Patient Discharge 1 Melphalan 1 Magnetic Resonance Imaging 1 Infusions, Intra-Arterial 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01637766 2020-08-03

SIAC

Weill Medical College of Cornell University

Phase 1 Completed

Spinal Cord Compression, Spinal Cord Neoplasms, Spinal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡